Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

How AbbVie Makes its Money (ABBV)
Investopedia
Wed, 04/1/15 - 05:38 pm
Tags:
AbbVie, Abbott Labs, spinoffs
Is Gilead Sciences Inc. About to Crater Before Our Very Eyes?
Motley Fool
Sun, 03/29/15 - 11:53 am
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi, AbbVie, Viekira Pak
The Pharmacyclics–AbbVie Merger: What Are the Details?
Yahoo/Market Realist
Sat, 03/28/15 - 10:28 am
Tags:
Pharmacyclics, AbbVie, M&A
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Tags:
Opdivo, Praluent, LCZ696, lumacaftor, Viekira Pak, evolocumab, Gardasil 9, brexpiprazole, Toujeo, Cosentyx, Bristol-Myers Squibb, Regeneron, Sanofi, Novartis, Pfizer, AbbVie, Amge, Astellas, Merck, Otsuka, Lundbeck, Vertex Pharmaceuticals
Could the Pharmacyclics–AbbVie Merger Get Competitive?
Yahoo/Market Realist
Tue, 03/24/15 - 03:13 pm
Tags:
AbbVie, Pharmacyclics, M&A, JNJ
Why 2015 is the year of the biopharma blockbuster—with charts
BioPharma Dive
Tue, 03/24/15 - 10:29 am
Tags:
biotech, Opdivo, Praluent, LCZ696, Ibrance, Viekira Pak, evolocumab, Gardasil 9, Bristol-Myers Squibb, Regeneron, Sanofi, Novartis, Pfizer, Vertex Pharmaceuticals, Merck, Amgen, AbbVie, Astellas
Drug Spending Is Soaring: 3 Takeaways You Can't Miss
Motley Fool
Sun, 03/22/15 - 10:43 am
Tags:
drug spending, Gilead Sciences, AbbVie
FDA panel recommends unblinding study after Imbruvica shows clear benefit
Yahoo/Reuters
Tue, 03/17/15 - 08:17 am
Tags:
FDA, advisory panels, Imbruvica, Pharmacyclics, JNJ, AbbVie
AbbVie Inc Viekira Pak Prescription Volumes Climb, Gilead Sciences, Inc. Harvoni Falls
Bidness Etc.
Fri, 03/13/15 - 12:08 pm
Tags:
AbbVie, Gilead Sciences, Harvoni, Viekira Pak, hepatitis C
Just where does AbbVie expect to find $7B in Imbruvica sales?
Fierce Pharma Marketing
Tue, 03/10/15 - 01:21 pm
Tags:
AbbVie, Imbruvica, M&A, Pharmacyclics
In Case You Missed It, Gilead Sciences, Inc.’s “Bad” News Is Actually Great
Motley Fool
Tue, 03/10/15 - 09:05 am
Tags:
Gilead Sciences, hepatitis C, AbbVie, Viekira Pak, Sovaldi, Harvoni
Amgen, Inc. Plans For Biosimilar Launches
Bidness Etc.
Tue, 03/10/15 - 08:21 am
Tags:
Amgen, biosimilars, Roche, AbbVie, Neupogen
Why AbbVie Inc.'s $21 Billion Deal Had To Happen
Motley Fool
Mon, 03/9/15 - 08:39 am
Tags:
AbbVie, M&A, Pharmacyclics
Is AbbVie (ABBV) Giving Up On Hepatitis C Market Due To Tough Competition From Gilead (GILD)?
Bidness Etc.
Sat, 03/7/15 - 11:07 am
Tags:
AbbVie, hepatitis C, Gilead Sciences, JNJ, Pfizer, Novartis
Expect More M&A Activity In Red-Hot Biotech Group
Investors.com
Fri, 03/6/15 - 03:09 pm
Tags:
biotech, M&A, AbbVie, Pharmacyclics, Isis Pharmaceuticals, JNJ, Merck, NewLink Genetics, Roche
It's A Drug! It's A Pipeline! It's A New Blockbuster Model!
Forbes
Fri, 03/6/15 - 08:33 am
Tags:
Pharmacyclics, AbbVie, M&A, Imbruvica
Bored by Golf and Cancer Cured, AbbVie CEO Came Back to Work
Bloomberg
Fri, 03/6/15 - 07:56 am
Tags:
Richard Gonzalez, Pharma CEOs, AbbVie, Pharmacyclics, M&A
Inside the $21 Billion War for a Blockbuster Cancer Drug
Yahoo/Bloomberg
Fri, 03/6/15 - 07:53 am
Tags:
AbbVie, Pharmacyclics, M&A, Imbruvica, JNJ
AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation'?
Fortune
Thu, 03/5/15 - 05:58 pm
Tags:
AbbVie, Pharmacyclics, M&A
Surprised, stunned and supportive: Analysts assess AbbVie's $21B Pharmacyclics deal
Fierce Biotech
Thu, 03/5/15 - 05:33 pm
Tags:
AbbVie, Pharmacyclics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.